Brought to you by 
Vyrix Pharmaceuticals files for its IPO; withdrawn
25 Nov 2014
Executive Summary
Vyrix Pharmaceuticals Inc. filed for its IPO. The company was created as a division of Ampio Pharmaceuticals Inc. in December 2013 to develop that firm’s sexual dysfunction therapies, and following the closing the IPO, will spin out as an independent entity.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Vyrix Pharmaceuticals files for its IPO; withdrawn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice